Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
author
Elshorbagy, Amany
Lyons, Alexander R.M.
Brandts, Julia
Catapano, Alberico L.
Hovingh, Gerard Kees Kornelis
statement of authorship
Amany Elshorbagy, Alexander R.M. Lyons, Antonio J. Vallejo-Vaz, Christophe A.T. Stevens, Kanika I. Dharmayat, Julia Brandts, Alberico L. Catapano, Tomas Freiberger, G. Kees Hovingh, M. Viigimaa et al.
source
The Lancet Diabetes and Endocrinology
publisher
journal volume number month
vol. 12, 11
year of publication
pages
p. 811-823
ISSN
2213-8587
notes
Bibliogr.: 28 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
language
inglise
subject term
keyword
TTÜ department
Elshorbagy, A., Lyons, A.R.M., Vallejo-Vaz, A.J., Stevens, C.A.T., Dharmayat, K.I., Brandts, J., Catapano, A.L., Freiberger, T., Hovingh, G. K., Viigimaa, M. et al. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study // The Lancet Diabetes and Endocrinology (2024) vol. 12, 11, p. 811-823. https://doi.org/10.1016/S2213-8587(24)00221-3